MARKET

ANVS

ANVS

Annovis Bio Inc
NYSE
1.790
0.000
0.00%
Opening 12:31 08/21 EDT
OPEN
1.780
PREV CLOSE
1.790
HIGH
1.840
LOW
1.770
VOLUME
377.12K
TURNOVER
--
52 WEEK HIGH
5.50
52 WEEK LOW
1.541
MARKET CAP
76.27M
P/E (TTM)
-1.0053
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP)
TipRanks · 2d ago
Annovis Bio’s New Long-Term Safety Study Puts Buntanetap Back in the Alzheimer’s Spotlight
TipRanks · 2d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amylyx Pharmaceuticals Inc (AMLX), Annovis Bio (ANVS) and BioMarin Pharmaceutical (BMRN)
TipRanks · 3d ago
Annovis Bio Price Target Maintained With a $17.00/Share by Canaccord Genuity
Dow Jones · 3d ago
Annovis Bio Is Maintained at Buy by Canaccord Genuity
Dow Jones · 3d ago
Weekly Report: what happened at ANVS last week (0810-0814)?
Weekly Report · 4d ago
Annovis Bio Q2 EPS $(0.40) Beats $(0.45) Estimate
Benzinga · 08/14 12:10
Annovis Bio GAAP EPS of -$0.40 beats by $0.05
Seeking Alpha · 08/14 12:05
More
About ANVS
Annovis Bio, Inc. is a late-stage clinical drug platform company addressing neurodegeneration such as Alzheimer’s disease (AD), and Parkinson’s disease (PD). The Company is developing its lead product candidate, Buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Buntanetap is a synthetically produced small molecule, orally administered, brain penetrant compound. Its product candidate ANVS405 is an intravenous drug being developed for acute indications and focused on protecting the brain after traumatic brain injury and/or stroke. ANVS405 is the same compound as Buntanetap, given in cases of acute head and brain trauma. ANVS301 is an orally administered drug being developed to increase cognitive capability in later stages of AD and dementia. ANVS301 is observed to improve memory and learning in very old rats by lowering the number of errors from over six to three.

Webull offers Annovis Bio Inc stock information, including NYSE: ANVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANVS stock methods without spending real money on the virtual paper trading platform.